Quantitative detection of cell free HPV DNA in liquid biopsy samples for cancer monitoring
)
Around 690,000 cancer cases are attributable to human papillomavirus (HPV) infection globally every year, most of them cervical (570,000) and oropharyngeal (42,000) cancers. Based on our current lab developed test*, that can quantitatively detect cell free HPV16/18 DNA in plasma samples, we strive to develop an assay in Kit format with matched performance that we will distribute directly to customers for use in sample preparation.
